思略特：2025从医疗科技到健康科技：赋能未来健康关怀生态系统研究报告（英文版）（27页）.pdf

1、From MedTech to WellTechEmpowering the Future WELLcare EcosystemBody textContactsGlobalAnthony BruceGlobal Health Industries LeaderPartner,PwC UK+44-7801-916-EuropeDr.Thomas Solbach Partner and Managing Director,Strategy&Germany+49-170-2238-Roland WernerHealth Industries Leader Germany Partner,PwC G

2、ermany+49-170-7628- Dr.Till GiesePartner,Strategy&Germany+49-151-5593-Harald DutzlerRetail and Consumer Leader EuropePartner,Strategy&Austria+43-664-515-United StatesJames WoodsPartner,Strategy&US+1-6177-847-JapanShunsuke Horii Asia Pacific Health Industries Leader Partner,PwC Japan+81-8033-176-Unit

3、ed KingdomThalita MarinhoPartner,Strategy&UK+44-790-016-IndiaSujay ShettyPartner,PwC India+91-98677-00030 ChinaJia Xu(Ph.D.)Partner,Strategy&China+86-10-6533-7734 3Body text3Dr.Thomas Solbach advises clients in the healthcare and life sciences industry globally.He specializes in helping biopharma,di

4、agnostics,MedTech and digital health solution providers todevelop and implement differentiated strategies,capabilities,innovations,and resilient operating models with a particular focus on precision medicine.He leads Strategy&s European pharma and life sciences practice.Based in Frankfurt,he is a Pa

5、rtner with Strategy&Germany.Dr.Till Giese is a Partner at Strategy&Germany,based in Hamburg.He advises internationalclients from the pharmaceutical,MedTech,and healthcare industries.With more than 18 yearsof industry experience,he specializes in strategy development and implementation,large scaletra

6、nsformations,innovation,digitization,and operational excellence.With this,he aims to leadclients to sustainable growth.Oliver Dolny is a Senior Manager at Strategy&Germany,where he supports clients in the MedTech and pharmaceutical industries on strategy development,transformation programs,and opera